Med. praxi. 2025;22(2):80-85 | DOI: 10.36290/med.2025.010

Modern management of tachyarrhythmias

MUDr. Ondřej Toman, Ph.D., MHA
Interní kardiologická klinika FN Brno a LF MU Brno

Arrhythmias are among the most common cardiologic disorders. They can affect even young individuals without any significant structural heart disease. However, they are more frequently associated with other cardiac or non-cardiac conditions or may complicate their course. Modern arrhythmia management is complex and relies on technologically advanced diagnostic and therapeutic approaches. Non-pharmacological treatment, particularly catheter ablation, is widely available and effective. This paper provides a brief overview of current options for the management and care of patients with tachyarrhythmias.

Keywords: tachyarrhythmias, catheter ablations, atrial fibrillation, electroporation.

Received: February 19, 2025; Accepted: February 20, 2025; Published: April 30, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Toman O. Modern management of tachyarrhythmias. Med. praxi. 2025;22(2):80-85. doi: 10.36290/med.2025.010.
Download citation

References

  1. Bulková V. Long­‑term ECG monitoring. Vnitr Lek. 2021;67:16-21. Go to original source...
  2. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2019;00:1-65.
  3. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics - 2019 update: a report from the American Heart Association. Circulation. 2019;139:e56-e528. Go to original source... Go to PubMed...
  4. John RM, Michaud GF, Stevenson WG, et al. Atrial fibrillation hospitalisation, mortality and therapy. Eur Heart J. 2018;39:3958-3960. Go to original source... Go to PubMed...
  5. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Gudelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio­‑Thoracic Surgery (EACTS). Eur Heart J. 2024;00:1-101. Go to original source... Go to PubMed...
  6. Osmancik P, Herman D, Neuzil P, et al. 4-Year Outcomes After Left Atrial Appendage Closure Versus Non­‑Warfarin Oral Anticoagulation for Atrial Fibrillation. J Am Coll Cardiol. 2022;79:1-14. Go to original source... Go to PubMed...
  7. Tzeis S, Gerstenfeld EP, Kalman J, et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2024;26:1-107. Go to original source... Go to PubMed...
  8. Phlips T, Taghji P, El Haddad M, et al. Improving procedural and one­‑year outcome after contact force­‑guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the "CLOSE"-protocol. Europace. 2018;20:f419-f427. Go to original source... Go to PubMed...
  9. Reddy VY, Neuzil P, Koruth JS, et al. Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation. J Am Coll Cardiol. 2019;74:315-326. Go to original source... Go to PubMed...
  10. Reddy VY, Anic A, Koruth JS, et al. Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation. J Am Coll Cardiol. 2020;76:1068-1080. Go to original source... Go to PubMed...
  11. Schmidt B, Bordignon S, Neven K, et al. EUropean real­‑world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi­‑centre EU­‑PORIA registry. Europace. 2023;25:euad185. Go to original source... Go to PubMed...
  12. Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2023;389:1660-1671. Go to original source... Go to PubMed...
  13. Muser D, Santangelli P, Castro SA, et al. Risk stratification of patients with apparently idiopathic premature ventricular contractions: multicenter international CMR registry. JACC Clin Electrophysiol. 2020;6:722-735. Go to original source... Go to PubMed...
  14. Latchamsetty R, Yokokawa M, Morady F, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol. 2015;1:116-123. Go to original source... Go to PubMed...
  15. Peichl P, Bulava A, Toman O, et al. Doporučení ESC pro diagnostiku a léčbu pacientů s komorovými arytmiemi a prevenci náhlé srdeční smrti 2022. Cor Vasa. 2023;65:186-235. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.